Anthony E Maida III's Net Worth

$893 Thousand

Estimate Recalculated Feb 7, 2024 03:52PM EST

Who is Anthony E Maida III?

Anthony E Maida III does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include SPECTRUM PHARMACEUTICALS INC, Oncotelic Therapeutics, Inc., Vitality Biopharma, Inc., INNOVATE BIOPHARMACEUTICALS, INC., ONCOSEC MEDICAL Inc, and Sirion Holdings, Inc..

SEC CIK

Anthony E Maida III's CIK is 0001273213

Past Insider Trading and Trends

2012 was Anthony E Maida III's most active year for acquiring shares with 11 total transactions. Anthony E Maida III's most active month to acquire stocks was the month of February. 2012 was Anthony E Maida III's most active year for disposing of shares, totalling 15 transactions. Anthony E Maida III's most active month to dispose stocks was the month of February. 2015 saw Anthony E Maida III paying a total of $427,030.00 for 349,000 shares, this is the most they've acquired in one year. In 2019 Anthony E Maida III cashed out on 154,381 shares for a total of $711,577.28, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

SPECTRUM PHARMACEUTICALS INC No price found

Investor

Anthony E Maida III owns 10,000 units of Common Stock $.001 par value, 3,250 units of Common Stock and 29,607 units of Common Stock, $0.001 par value. From 2003 to 2019 Anthony E Maida III acquired a total of 287,700 shares in SPECTRUM PHARMACEUTICALS INC at a cost of $1,189,585.00, Anthony also disposed a total of 232,542 shares of SPECTRUM PHARMACEUTICALS INC equalling to $2,055,690.34.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+33.07%
7.36K
$6.92
-$25,855.32
29.61K
May 29
Form 4
-32.55%
-10.74K
$10.67
-$114,574.46
22.25K
Scheduled
Apr 11
Form 4
—
0
$7.53
-$27,225.00
32.99K
Scheduled
Mar 21
Form 4
—
0
$8.34
-$36,190.00
32.99K
Scheduled
Feb 21
Form 4
—
0
$7.59
-$40,321.50
32.99K
Scheduled
Jan 24
Form 4
—
0
$6.96
-$44,080.00
32.99K
Scheduled
Jan 7
Form 4
—
0
$8.26
-$62,930.00
32.99K
Scheduled
Dec 6
Form 4
—
0
$8.50
-$66,337.50
32.99K
Scheduled
Nov 8
Form 4
+43.50%
10K
—
—
32.99K
Jun 18
Form 4
+3.67%
813
$7.22
-$3,328.11
22.99K
Jul 17
Form 4
-3.82%
-880.00
$7.54
-$6,635.20
22.18K
Jun 27
Form 4
+39.07%
6.48K
$6.48
-$22,829.04
23.05K
Jun 13
Form 4
+23.18%
5.6K
$6.36
-$27,994.19
29.75K
Jun 27 - Jun 28
Form 4
-3.35%
-881.00
$6.96
-$6,131.76
25.46K
Jul 7
Form 4
+61.21%
10K
—
—
26.34K
Jun 29
Form 4
-3.38%
-960.00
$6.88
-$15,616.00
27.41K
Dec 13 - Dec 15
Form 4
+13.92%
3.47K
$7.15
-$15,570.84
28.37K
Jul 9
Form 4
+57.76%
9.12K
$7.94
-$6,995.14
24.91K
Jun 27
Form 4
-10.04%
-1.76K
$8.42
-$14,836.04
15.79K
Jun 13
Form 4
+132.45%
10K
—
—
17.55K
Dec 13
Form 4
—
0
$7.71
-$37,898.50
7.55K
Scheduled
Mar 5
Form 4
—
0
$8.20
-$40,522.50
2.25K
Scheduled
Feb 5
Form 4
—
0
$7.84
-$35,809.00
2.25K
Scheduled
Jan 2
Form 4
+235.56%
5.3K
$11.34
$60,102.00
7.55K
Dec 19
Form 4
—
0
$7.96
-$36,965.00
2.25K
Scheduled
Dec 4
Form 4
—
0
$7.11
-$39,782.04
2.25K
Scheduled
Nov 1
Form 4
—
0
$9.23
-$25,759.00
2.25K
Scheduled
Oct 2
Form 4
—
0
$9.33
-$26,790.00
2.25K
Scheduled
Sep 4
Form 4
—
0
$7.66
-$58,271.00
2.25K
Mar 5 - Mar 6
Form 4
—
0
—
—
0
Jun 12
Form 4
—
0
$5.07
-$15,120.00
2.25K
May 13
Form 4
—
0
$3.51
-$9,559.50
2.25K
Nov 16
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Apr 20
Form 4
-79.55%
-8.75K
$3.59
-$67,430.70
2.25K
Oct 14
Form 4
—
0
—
—
0
Jun 26
Form 4
∞
1K
$5.15
$5,150.00
1K
May 20
Form 4
—
0
—
—
0
Mar 25
Form 4
+100.00%
5K
—
—
10K
Jul 20
Form 4
—
0
—
—
0
Feb 20
Form 4
∞
5K
—
—
5K
Dec 6
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jul 10
Form 4
—
0
—
—
0
Dec 12
Form 3
—
0
—
—
0
No matching records found

Oncotelic Therapeutics, Inc. (OTLC) Snapshot price: $0.03975

Chief Clin. Ops. Officer

Anthony E Maida III owns 1,137,314 units of Common Stock which is worth $45,208.23. In the year 2020 Anthony E Maida III acquired a total of 938,646 shares in Oncotelic Therapeutics, Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 3
Form 4
+472.47%
938.65K
—
—
1.14M
Mar 31 - Jul 8
Form 3
—
0
—
—
0
No matching records found

Vitality Biopharma, Inc. (MLCT) Snapshot price: $0.195

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 8
Form 4
—
0
—
—
0
Jul 30 - Jul 15
Form 3
—
0
—
—
0
No matching records found

INNOVATE BIOPHARMACEUTICALS, INC. (NMTRQ) Snapshot price: $0.000001

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 24
Form 4
—
0
—
—
0
May 31
Form 4
—
0
—
—
0
Dec 4
Form 3
—
0
—
—
0
No matching records found

ONCOSEC MEDICAL Inc (ONCSQ) Snapshot price: $0.0001

Investor

Anthony E Maida III owns 45,600 units of Common Stock which is worth $4.56. From 2011 to 2017 Anthony E Maida III acquired a total of 22,800 shares in ONCOSEC MEDICAL Inc at a cost of $18,564.60.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 29
Form 4/A
—
0
—
—
0
Mar 4
Form 4
—
0
—
—
0
Mar 4
Form 4
—
0
—
—
0
Aug 20
Form 4
—
0
—
—
0
Mar 3
Form 4
+25.00%
22.8K
$0.81
$18,564.60
114K
Mar 20
Form 4
—
0
—
—
0
Mar 7
Form 4
—
0
—
—
0
Apr 15
Form 4
—
0
—
—
0
Apr 25
Form 4
—
0
—
—
0
Sep 27
Form 3
—
0
—
—
0
No matching records found